|Articles|April 1, 2016

Redefining Easy

The life science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the United States and Canada, offers a broad range of products that span from research and development to production. Visit booth #2841 to learn how our new product innovations will help you simplify your manufacturing processes, allowing you to advance your molecules to market faster and more cost effectively.

MilliporeSigma
INTERPHEX Booth #2841

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!

Redefining Easy

Newsletter

Trending on BioPharm International

How CDMO Alliances Can Provide End-to-End Service that Reduces Drug Development Time and Costs

First-in-Human Study Validates Safety of Next-Generation mRNA–LNP Platform

Industry Outlook 2026: Key Forces Transforming Drug Pipelines (Part 2)

FDA Clears PharmaResearch IND for Nano-Based Cancer Drug PRD-101

High-Dose Nusinersen Slows Neurodegeneration in SMA Patients, Study Shows